On the basis of our previous results indicating that TSH can downregulate GLUT4 expression and inhibit GLUT4 translocation to the plasma membrane [9], we speculate that TSH might play a pivotal role in the development of insulin resistance and that TSH is an important therapeutic target for improvement of insulin resistance. The gene discussed is SLC2A4; the disease is Insulin resistance.